These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2275224)

  • 41. A New Cutoff for Abnormal Proteinuria in Diabetes Mellitus Patients: Relationship to Albuminuria.
    Erman O; Erman A; Vodonos A; Gafter U; van Dijk DJ
    Isr Med Assoc J; 2016 Jul; 18(7):418-421. PubMed ID: 28471565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin-converting enzyme inhibition and diabetic nephropathy.
    Beaufils M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S33-8. PubMed ID: 1382163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of prostaglandin E1 on heavy proteinuria in slightly azotaemic diabetics.
    Okada S; Sato K; Higuchi T; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    J Int Med Res; 1991; 19(2):171-3. PubMed ID: 1864454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of trental on indices kidney function in diabetes mellitus].
    Blagosklonnaia IaV; Mamedov R; Kozlov VV; Emanuél' VL; Kudriashova MI
    Probl Endokrinol (Mosk); 1982; 28(3):3-8. PubMed ID: 7100130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertension, proteinuria and azotaemia in diabetes.
    Braude M; Osler C; Taylor D; Kalk WJ
    S Afr Med J; 1991 Nov; 80(9):431-3. PubMed ID: 1948496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
    Kuriyama S; Tomonari H; Abe A; Imasawa T; Hosoya T
    Nephron; 2000 Dec; 86(4):529-30. PubMed ID: 11124615
    [No Abstract]   [Full Text] [Related]  

  • 48. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
    Navarro-González JF; Muros M; Mora-Fernández C; Herrera H; Meneses B; García J
    J Diabetes Complications; 2011; 25(5):314-9. PubMed ID: 21144773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reducing complications in type 2 diabetes.
    Poirier SJ
    Am Fam Physician; 1998 Mar; 57(6):1238-9. PubMed ID: 9531907
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
    Solerte SB; Adamo S; Viola C; Zambianchi E; Ferrari E
    Ric Clin Lab; 1985; 15 Suppl 1():515-26. PubMed ID: 4035232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiproteinuric effect of angiotensin receptor blockers in normotensive patients with proteinuria: a meta-analysis of randomized controlled trials.
    Geng DF; Sun WF; Yang L; En G; Wang JF
    J Renin Angiotensin Aldosterone Syst; 2014 Mar; 15(1):44-51. PubMed ID: 23378528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Romero R; Salinas I; Teixidó J; Lucas A; Felip A; Sanmarti A
    J Hum Hypertens; 1990 Dec; 4(6):671-5. PubMed ID: 2096209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening and treatment of diabetic renal disease.
    Clement JD; Cottiero RA
    Med Health R I; 1998 Nov; 81(11):348-9. PubMed ID: 15580788
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diabetes mellitus and development of kidney insufficiency].
    Pap I; Reinecke U
    Z Gesamte Inn Med; 1990 Aug; 45(16):485-7. PubMed ID: 2260364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of role of doxycycline (a matrix metalloproteinase inhibitor) on renal functions in patients of diabetic nephropathy.
    Aggarwal HK; Jain D; Talapatra P; Yadav RK; Gupta T; Kathuria KL
    Ren Fail; 2010; 32(8):941-6. PubMed ID: 20722561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The renoprotective potential of pentoxifylline in chronic kidney disease.
    Lin SL; Chiang WC; Chen YM; Lai CF; Tsai TJ; Hsieh BS
    J Chin Med Assoc; 2005 Mar; 68(3):99-105. PubMed ID: 15813241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
    Spesivtseva VG; Kasabian IN; Mamaeva GG; Kukes VG
    Sov Med; 1980; (2):64-9. PubMed ID: 6987747
    [No Abstract]   [Full Text] [Related]  

  • 58. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
    Liou HH; Huang TP; Campese VM
    Nephron; 1995; 69(1):41-8. PubMed ID: 7891796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.